Since polymorphisms in the HSD11B1 gene have been associated with increased risk for Alzheimer's disease [35] and susceptibility to incident depression [36], HSD11B1 inhibitors should specifically be tested for their effects in patients affected by Alzheimer's disease or depression (Additional file 3). Here, HSD11B1 is linked to depressive symptom measurement.